Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.

van Noesel MM, Orbach D, Brennan B, Kelsey A, Zanetti I, de Salvo GL, Gaze MN, Craigie RJ, McHugh K, Francotte N, Collini P, Bisogno G, Casanova M, Ferrari A.

Pediatr Blood Cancer. 2019 Jun 26:e27833. doi: 10.1002/pbc.27833. [Epub ahead of print]

PMID:
31241238
2.

Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).

Brennan B, Zanetti I, Orbach D, Gallego S, Francotte N, Van Noesel M, Kelsey A, Casanova M, De Salvo GL, Bisogno G, Ferrari A.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26942. Epub 2017 Dec 29.

PMID:
29286582
3.

Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).

Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C.

Eur J Cancer. 2016 Mar;56:77-84. doi: 10.1016/j.ejca.2015.12.015. Epub 2016 Jan 26.

PMID:
26824706
4.

Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.

Brennan B, De Salvo GL, Orbach D, De Paoli A, Kelsey A, Mudry P, Francotte N, Van Noesel M, Bisogno G, Casanova M, Ferrari A.

Eur J Cancer. 2016 Jun;60:69-82. doi: 10.1016/j.ejca.2016.02.027. Epub 2016 Apr 13.

PMID:
27082136
5.

Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).

Ferrari A, De Salvo GL, Brennan B, van Noesel MM, De Paoli A, Casanova M, Francotte N, Kelsey A, Alaggio R, Oberlin O, Carli M, Ben-Arush M, Bergeron C, Merks JH, Jenney M, Stevens MC, Bisogno G, Orbach D.

Ann Oncol. 2015 Mar;26(3):567-72. doi: 10.1093/annonc/mdu562. Epub 2014 Dec 8.

PMID:
25488687
6.

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

Kroep JR, Ouali M, Gelderblom H, Le Cesne A, Dekker TJ, Van Glabbeke M, Hogendoorn PC, Hohenberger P.

Ann Oncol. 2011 Jan;22(1):207-14. doi: 10.1093/annonc/mdq338. Epub 2010 Jul 23.

7.

Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.

Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM.

Am J Clin Oncol. 2011 Aug;34(4):417-21. doi: 10.1097/COC.0b013e3181e9c08a.

PMID:
20838322
8.

Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.

Miao R, Wang H, Jacobson A, Lietz AP, Choy E, Raskin KA, Schwab JH, Deshpande V, Nielsen GP, DeLaney TF, Cote GM, Hornicek FJ, Chen YE.

Radiother Oncol. 2019 Aug;137:61-70. doi: 10.1016/j.radonc.2019.03.015. Epub 2019 May 9.

PMID:
31078939
9.

The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.

Ferrari A, Brecht IB, Koscielniak E, Casanova M, Scagnellato A, Bisogno G, Alaggio R, Cecchetto G, Catania S, Meazza C, Int-Veen C, Kirsch S, Dantonello T, Carli M, Treuner J.

Pediatr Blood Cancer. 2005 Aug;45(2):128-34.

PMID:
15852434
10.

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.

Higham CS, Steinberg SM, Dombi E, Perry A, Helman LJ, Schuetze SM, Ludwig JA, Staddon A, Milhem MM, Rushing D, Jones RL, Livingston M, Goldman S, Moertel C, Wagner L, Janhofer D, Annunziata CM, Reinke D, Long L, Viskochil D, Baker L, Widemann BC.

Sarcoma. 2017;2017:8685638. doi: 10.1155/2017/8685638. Epub 2017 Sep 12.

11.

Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications.

Waxweiler TV, Rusthoven CG, Proper MS, Cost CR, Cost NG, Donaldson N, Garrington T, Greffe BS, Heare T, Macy ME, Liu AK.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):339-48. doi: 10.1016/j.ijrobp.2015.02.007.

PMID:
25968827
12.

Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.

Kahn J, Gillespie A, Tsokos M, Ondos J, Dombi E, Camphausen K, Widemann BC, Kaushal A.

Front Oncol. 2014 Nov 17;4:324. doi: 10.3389/fonc.2014.00324. eCollection 2014.

13.

Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.

Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, Cecchetto G, Alaggio R, De Sio L, Koscielniak E, Sotti G, Treuner J.

J Clin Oncol. 2005 Nov 20;23(33):8422-30. Erratum in: J Clin Oncol. 2006 Feb 1;24(4):724. Koscielniak, Eura [corrected to Koscielniak, Ewa].

PMID:
16293873
14.

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG.

Lancet Oncol. 2017 Jun;18(6):812-822. doi: 10.1016/S1470-2045(17)30334-0. Epub 2017 May 9. Erratum in: Lancet Oncol. 2017 Jun;18(6):e301.

PMID:
28499583
15.

Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience.

Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, Wasif N.

Ann Surg Oncol. 2012 Mar;19(3):878-85. doi: 10.1245/s10434-011-1978-7. Epub 2011 Aug 23.

PMID:
21861229
16.

Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.

LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S.

Ann Surg Oncol. 2013 Jan;20(1):66-72. doi: 10.1245/s10434-012-2573-2. Epub 2012 Aug 10.

17.

Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.

Chou D, Bilsky MH, Luzzati A, Fisher CG, Gokaslan ZL, Rhines LD, Dekutoski MB, Fehlings MG, Ghag R, Varga P, Boriani S, Germscheid NM, Reynolds JJ; AOSpine Knowledge Forum Tumor.

J Neurosurg Spine. 2017 Mar;26(3):291-298. doi: 10.3171/2016.8.SPINE151548. Epub 2016 Nov 11.

PMID:
27834629
18.

[A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].

Malerba M, Garofalo A.

Tumori. 2003 Jul-Aug;89(4 Suppl):246-50. Italian.

PMID:
12903608
19.

Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.

Lamm W, Schur S, Köstler WJ, Funovics P, Windhager R, Amann G, Panotopoulos J, Pokrajac B, Brodowicz T.

Oncology. 2014;86(2):122-6. doi: 10.1159/000357137. Epub 2014 Jan 28.

PMID:
24480823
20.

Soft-tissue sarcomas of the extremities in patients of pediatric age.

Casanova M, Meazza C, Gronchi A, Fiore M, Zaffignani E, Podda M, Collini P, Gandola L, Ferrari A.

J Child Orthop. 2007 Sep;1(3):195-203. doi: 10.1007/s11832-007-0042-4. Epub 2007 Sep 1.

Supplemental Content

Support Center